Mondays with Dr. Mark & Dr. Michael
Not a member and interested in attending? Contact Emily Commer!
Changing the Odds: Lung Cancer, New Advances, and the Employer Experience
Dr. Mark & Dr. Michael will be joined by an expert from Memorial Sloan Kettering Cancer Center and an employer to explore breakthroughs in lung cancer care alongside the realities of helping employees navigate diagnosis, treatment, and recovery.
Featured Speaker
Alexis Chidi, MD, PhD, MSPH
Dr. Chidi is a Thoracic Surgeon and serves as Co-Director of MSK’s Lung Cancer Screening Program, which works with people at higher risk of lung cancer to find and treat suspicious lung nodules before cancer spreads. She is highly trained in using the latest minimally invasive techniques including robotic bronchoscopy, advanced endoscopy, video-assisted thoracoscopy (VATS), and robotic surgery.
Dr. Chidi’s approach when it comes to surgery is to always talk with her patients to decide whether a minimally invasive approach is possible, walking them through every part of the process, from pre-operative preparation to the surgical plan to the expectations for recovery in the hospital and at home.
While not in the operating room or clinic, Dr. Chidi devotes her time to clinical research focused on improving access to lung cancer screening, clinical trials, and the latest treatments for cancers of the chest. She is also involved in policy and advocacy efforts to make it easier for patients to receive the highest-quality cancer care.
She became a thoracic surgeon because it allowed her the chance to treat patients facing challenging diagnoses with empathy and compassion while providing them with high-quality surgical care and access to advanced surgical techniques.
With
Dr. Mark Cunningham-Hill
Dr. Cunningham-Hill is an employee health expert known for his ability to create, identify and implement high-quality workplace health programs including prevention and screening, chronic illness interventions, and mental health and wellbeing initiatives. His broad occupational medicine and public health experience encompasses addressing chronic diseases impacting employers, employees and communities within the context of social, cultural and racial determinants of health.
Mark has served as the Medical Director for Northeast Business Group on Health since early 2018. Until 2017, he served as Senior Director, Global Solutions Center and Head of Occupational Medicine at Johnson & Johnson, Inc . At J&J, Mark led a team of experts covering occupational medicine, health and wellness, personal energy management, EAP and mental wellbeing, and work-life effectiveness, and supported regional operational groups delivering health services to 135,000 employees in 120 companies. Prior to seven years at J&J, Mark spent 17 years at GlaxoSmithKline in both London and Philadelphia, including as Head of Global Operations, Employee Health Management.
Mark received his MB ChB, Bachelor of Medicine and Bachelor of Surgery at Manchester University in the UK. He is a Fellow of both the American College of Occupational & Environmental Medicine, and the Faculty of Occupational Medicine, London.
Michael Rendel, MD - Advisory Board Member
Michael is the firm’s global medical advisor. He is also a senior managing director champion from the Human Capital Management Division for the Disability Interest Forum. Previously, Michael served as global head of Benefits and Wellness until 2019. He joined Goldman Sachs in 2009 as US medical director and was named managing director in 2013.
Prior to joining the firm, Michael was medical director at Merrill Lynch from 2007 to 2009. Previously, he was a physician in private practice in Manhattan from 1990 to 2007, specializing in internal medicine and infectious diseases. During that time, Michael also served as a medical consultant at Merrill Lynch.
He serves on the board of the Northeast Business Group on Health. From 2009 to 2017, Michael also served on the board of Fedcap, a nonprofit that works to remove barriers to employment for the disabled and disadvantaged.
Michael earned a BA in Biology from Brown University in 1979 and an MD from the University of Maryland in 1984. He completed his training in Internal Medicine at Medical College of Pennsylvania in 1987 and in Infectious Diseases at New York University in 1990.